JP4593918B2 - 胆汁分泌促進、結石溶解作用を有する一種の薬物組成物、及びその製造方法 - Google Patents

胆汁分泌促進、結石溶解作用を有する一種の薬物組成物、及びその製造方法 Download PDF

Info

Publication number
JP4593918B2
JP4593918B2 JP2003539701A JP2003539701A JP4593918B2 JP 4593918 B2 JP4593918 B2 JP 4593918B2 JP 2003539701 A JP2003539701 A JP 2003539701A JP 2003539701 A JP2003539701 A JP 2003539701A JP 4593918 B2 JP4593918 B2 JP 4593918B2
Authority
JP
Japan
Prior art keywords
ldrs
drug
solution
test
stone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2003539701A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005514343A5 (enExample
JP2005514343A (ja
Inventor
シャオ、ウェイ
ヤン、イン
リン、ヤ
リ、ミンフイ
リアオ、ジェンゲン
ジャン、チェンフェン
カオ、シュボ
Original Assignee
ジャンスカンユアンヤオイエグフェンヨウシャンゴンシ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジャンスカンユアンヤオイエグフェンヨウシャンゴンシ filed Critical ジャンスカンユアンヤオイエグフェンヨウシャンゴンシ
Publication of JP2005514343A publication Critical patent/JP2005514343A/ja
Publication of JP2005514343A5 publication Critical patent/JP2005514343A5/ja
Application granted granted Critical
Publication of JP4593918B2 publication Critical patent/JP4593918B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315—Isatis, e.g. Dyer's woad
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
JP2003539701A 2001-10-29 2002-09-05 胆汁分泌促進、結石溶解作用を有する一種の薬物組成物、及びその製造方法 Expired - Lifetime JP4593918B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB011340908A CN1179735C (zh) 2001-10-29 2001-10-29 一种治疗肝胆结石的溶石性药物及制备方法
PCT/CN2002/000622 WO2003037358A1 (en) 2001-10-29 2002-09-05 A pharmaceutical composition having cholagogic and litholytic effect and its preparation method

Publications (3)

Publication Number Publication Date
JP2005514343A JP2005514343A (ja) 2005-05-19
JP2005514343A5 JP2005514343A5 (enExample) 2008-10-23
JP4593918B2 true JP4593918B2 (ja) 2010-12-08

Family

ID=4672224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003539701A Expired - Lifetime JP4593918B2 (ja) 2001-10-29 2002-09-05 胆汁分泌促進、結石溶解作用を有する一種の薬物組成物、及びその製造方法

Country Status (4)

Country Link
US (1) US20050042308A1 (enExample)
JP (1) JP4593918B2 (enExample)
CN (1) CN1179735C (enExample)
WO (1) WO2003037358A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102210742B (zh) * 2010-04-09 2013-06-05 四川济生堂药业有限公司 薄荷素油在制备治疗胆汁淤积性肝病的药物中的应用
CN112516213B (zh) * 2020-12-30 2022-06-17 广西中医药大学 一种治疗胆结石的瑶药组合物、汤剂、胶囊剂及其应用
CN113421620B (zh) * 2021-05-17 2025-04-29 陕西中医药大学 基于uplc-q-tof/mse和整合效应的bp神经网络关联分析对中药不同功效的生物活性成分进行模糊识别的方法
CN113624707B (zh) * 2021-09-17 2024-06-18 云南博瑞生物科技有限公司 一种萝卜红气味定量检测方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60172925A (ja) * 1984-02-17 1985-09-06 Kao Corp 胆石溶解剤
JPH0757734B2 (ja) * 1990-10-09 1995-06-21 呉羽化学工業株式会社 鎮静用香料組成物および香粧品
CN1060964A (zh) * 1990-10-29 1992-05-13 洛洪程 一种热伤药物的制取方法
DE4330664A1 (de) * 1993-09-10 1995-03-16 Beiersdorf Ag Verwendungen von Pflanzenölen
JPH07242536A (ja) * 1994-03-01 1995-09-19 Toyo Capsule Kk 皮膜に精油成分が含有されたゼラチンカプセル剤
JP3828163B2 (ja) * 1994-06-10 2006-10-04 サンスター株式会社 抗炎症、抗かゆみ剤
EP0842604A1 (en) * 1996-11-13 1998-05-20 The Procter & Gamble Company Sprayable disinfecting compositions and processes for disinfecting surfaces therewith
IL129102A0 (en) * 1999-03-22 2000-02-17 J P M E D Ltd An emulsion
EP1146112A1 (en) * 2000-04-14 2001-10-17 The Procter & Gamble Company Process of cleaning and/or disinfecting a hard surface with a composition comprising a biguanide antimicrobial agent

Also Published As

Publication number Publication date
CN1179735C (zh) 2004-12-15
US20050042308A1 (en) 2005-02-24
CN1358530A (zh) 2002-07-17
WO2003037358A1 (en) 2003-05-08
JP2005514343A (ja) 2005-05-19

Similar Documents

Publication Publication Date Title
VATNIKOV et al. Clinical and hematological parameters for selecting the optimal dose of the phytopreparation" Deprim", containing an extract of the herb Hypericum perforatum L., in husbandry.
MOUNDIPA In vitro amoebicidal activity of some medicinal plants of the Bamun region (Cameroon)
JP2004507499A (ja) クエルセチン誘導体を有効成分として含有する骨粗鬆症治療剤
CN101947202A (zh) 兽用微乳剂及其制备方法
Crellin Home medicine: the Newfoundland experience
JP2005514343A (ja) 胆汁分泌促進、結石溶解作用を有する一種の薬物組成物、及びその製造方法
CN105595346B (zh) 一种用于补钙的液体制剂及其制备方法
Berreghioua et al. Phytochemical screening and antibacterial activity of some extracts from Atriplex halimus Growing in Algerian Sahara
CN100428925C (zh) 一种香薷提取物的制剂、质量控制方法
CN102188494A (zh) 一种纯中药治疗猪高热病的药物
CN102028680B (zh) 漆黄素在制备抗柔嫩艾美耳球虫药物中的应用
JP2005514343A5 (enExample)
CN106177227A (zh) 一种增强人体免疫力的含辅酶q10的组合物
Garg et al. Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation
Ogunlusi In-Vivo Studies of the Trypanocidal and Toxicity Activities of Aframomum melegueta (Alligator Pepper)
Maduagwuna et al. nHexane Extract of Caryota no Seeds Modulates Survival and Longevity in Drosophila Melanogaster
CN102018687B (zh) 六氯酚在制备抗柔嫩艾美耳球虫药物中的应用
Schwab The development of a herbal preparation for the treatment of diarrhea in dogs
CN109364046A (zh) 雪松醇及其药用衍生物在制备抗柔嫩艾美耳球虫药物中的应用
Zaman et al. Deciphering the Comparative Pharmacological Insights of Thysanolaena maxima, Diploclisia glaucescens, and Pterospermum semisagittatum: Chemico-Biological Investigations
Muhammad Bioactivity guided isolation of active principles from spondias pinnata of Bangladesh
Srijith Effect of Ekasara Gana Drugs (Vidanga, Shireesha, Sinduvaraka) on Staphylococcus Aureus WSR to Food Poison-An Invitro Study
Rotti Pharmacognostical and Experimental Study of Different Sources of Moorva WSR to Antipyretic Activity
CN106420769A (zh) β‑谷甾醇在制备抗柔嫩艾美耳球虫药物中的应用
KR20190076687A (ko) 오메가-3 지방산 및 우르소데옥시콜산(udca)을 포함하는 콜레스테롤 담석 예방 또는 치료용 약학적 조성물 및 이의 제조방법

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080507

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080806

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080813

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20080904

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091110

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100210

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100413

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100713

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100817

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100916

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130924

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4593918

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term